News Press Releases

Hims & Hers Appoints Two New Board Members

HIMS | March 10, 2021

Andrea Perez and Ambar Bhattacharyya Join Hims & Hers Board of Directors To Help the Company Pioneer a Better Way for Patients to Access Healthcare

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced the appointment of Andrea Perez and Ambar Bhattacharyya to the company’s Board of Directors. Following the company’s recent entry onto the NYSE, Perez and Bhattacharyya join Hims & Hers at a pivotal moment not only for the brand, but at an inflection point in the healthcare industry as the COVID-19 pandemic has accelerated the need for equitable access to healthcare and highlighted the value of telemedicine.

“As we continue our work of reimagining the modern healthcare experience, I am thrilled to have both Andrea Perez and Ambar Bhattacharyya joining us on this mission,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “Andrea and Ambar each bring their own unique perspectives and proficiencies in scaling world class brands, adding immense value to our Board as we strive to make access to healthcare easier, safer and more affordable for as many people as possible.”

Andrea Perez is a proven leader at Nike, where she is currently Jordan Brand’s Global Vice President and General Manager of Women’s. Perez brings deep industry experience in scaling consumer businesses to her new position on the Hims & Hers Board of Directors. Over the last two decades, Andrea has worked to drive deeper consumer connections and global growth for Nike, one of the world’s most influential consumer brands.

“Hims & Hers is modernizing healthcare by combining consumer product aspects of the industry with direct servicing through telemedicine while utilizing and enhancing societal interest in wellness overall,” said Perez. “The brand’s crossover between culture and health is a unique advantage, and what I believe is the way of the future when it comes to healthcare. I’m looking forward to leveraging my deep knowledge of harnessing consumer and cultural insights to help Hims & Hers empower and enable more people to access quality care.”

Ambar Bhattacharyya, a healthcare industry expert with more than a decade of experience investing in young, mission-driven companies, was first drawn to Hims & Hers as an early investor by the company’s pioneering approach to providing real-time care to all patients through an affordable, user-friendly platform. As Managing Director at Maverick Ventures, the venture capital arm of Maverick Capital, Bhattacharyya is actively involved in leading investments in the healthcare sector. His passion in supporting and guiding companies that are improving the healthcare experience for providers and patients alike has garnered him broad recognition—being named on numerous awards lists from Fortune Magazine's "40 under 40" to Business Insider’s “30 leaders under 40 transforming healthcare.” Passionate about driving change in healthcare, Ambar yields a host of expertise working with other innovators in the space as a board member and investor.

“Quite simply, Hims & Hers is redefining what consumer healthcare is,” said Bhattacharyya. “This is a telehealth company that is turning the healthcare system on its head, and putting the power into the hands of the consumer when it comes to defining their own healthcare experience. After being an observer on the Board for the past few years, I can confidently call Hims & Hers one of the most consumer-centric companies in the healthcare space and I’m honored to formally join as a Board member. I look forward to guiding and watching the Hims & Hers team during its journey to disrupt the traditional healthcare model in a safe, welcoming, and effective way for all.”

Founded in 2017, Hims & Hers has continued on a rapid trajectory towards building a digital front door to the healthcare system in providing consumers with a patient-friendly entry point. In January 2021, the company was listed on the NYSE at an initial valuation of $1.6 billion and is traded under the ticker symbol “HIMS”.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com .

Cautionary Note Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Hims & Hers Health, Inc. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission (“SEC”) filings, including those set forth in the Risk Factors section and under the heading “Cautionary Note Regarding Forward-Looking Statements” in our Registration Statement on Form S-1. You are cautioned not to place undue reliance on Hims & Hers Health, Inc.'s forward looking statements. Hims & Hers Health, Inc.'s forward-looking statements are and will be based upon management’s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. Hims & Hers Health, Inc. does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.